查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1554203

医疗仿生技术市场规模、份额、趋势分析报告：按类型、应用、区域、细分市场预测，2024-2030

Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology, Dental), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

医学仿生技术市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球医学仿生技术市场规模预计将达到553.6亿美元，2024年至2030年复合年增长率为7.6%。

奈米技术的进步、对义肢和植入的需求不断增加、与医学仿生技术相关的研发活动的增加以及主要市场参与者的策略活动是推动市场成长的主要因素。例如，2021年4月，curasan AG扩大了在欧洲的销售网络，该公司将Silesia Dental和Implants Diffusion International SARL纳入其欧洲销售网络。

影响角膜的疾病是全世界失明的最重要原因。据世界卫生组织称，每年约有 200 万新发角膜失明病例。全球有超过 3000 万人因角膜疾病或受伤而导致一隻或双眼失明，有些人视力丧失。创造可靠、稳健和扩充性的人工角膜解决方案的许多尝试都失败了。因此，存在未满足的需求，并且正在进行研究和开发工作，以寻找负担得起且持久的病理、损伤和角膜失明的解决方案。例如，2022 年3 月，印度理工学院海得拉巴分校LV Prasad 眼科研究所的研究人员将生产一种由废弃的人类角膜製成的新产品，可用于治疗角膜疤痕，这是导致角膜失明的主要原因。

在医疗仿生技术市场，许多公司正在新兴市场拓展产品。例如，最重要的新进展是，2021年11月，Osteopore的智慧3D仿生支架在中国获得了专利。该技术是与新加坡南洋理工大学的科学家共同开发的，并于 2021 年初获得了欧洲专利。该专利预计将在中国市场创造许多研发机会，使该公司能够利用当地的专业知识作为其产品开发过程的一部分。

COVID-19大流行预计将对医疗仿生技术市场的成长产生负面影响。 COVID-19 大流行对寻求牙科护理的患者数量产生了相当大的影响。总体而言，约旦医院接受治疗的患者人数减少了约 90.4%（从 17,591 人减少至 1,689 人）。因此，在 COVID-19 大流行期间，这些技术的使用较少。

此外，随着事故数量的增加，仿生学在整形外科的引入预计将蓬勃发展。根据国际安全道路旅行协会的数据，全球每年约有 2,000 万至 5,000 万人遭受残疾伤害。因此，这些因素预计将对医疗仿生技术市场的成长产生正面影响。

另一方面，严格的法律规范正在阻碍医学仿生技术产业的发展。随着仿生生物材料的应用日益增加并在许多医学领域受到欢迎，对其的准确评估非常重要。儘管每种生医材料都经过彻底的上市前评估，但监管机构每年都会收到大量不利事件和併发症的报告。此外，由于生物材料被纳入生物系统，因此它们必须满足所有科学要求，例如高生物相容性、足够长的保质期以及与生物相互作用的相容性。

医学仿生技术市场报告亮点

  • 在医学仿生技术市场中，按类型划分，心血管领域占最大份额。这是因为对心血管疾病的研究活动的增加和调查数量的增加预计将增加仿生技术的采用并扩大医学仿生技术市场。
  • 预计创伤治疗领域在预测期内将呈指数级增长。手术病例数量的增加和慢性病的全球流行增加了对创伤治疗和创伤护理产品的需求。
  • 由于奈米技术的重大发展促进了使用基于仿生技术的设备进行高效和精确的非载体药物输送，医疗仿生技术市场的药物输送领域预计将以最快的速度增长。充足的资金和研发的进步将促进医学仿生技术市场的成长。
  • 由于高研发投入、新产品的市场开拓以及该地区政府的大力资助，北美在 2023 年将主导全球医疗仿生技术市场。
  • 由于慢性病盛行率不断上升以及主要市场参与者业务的扩张，预计亚太地区未来几年将显着成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章医学仿生技术市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 医学仿生技术市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 医学仿生技术市场：依类型估算及趋势分析

  • 细分仪表板
  • 医疗仿生技术市场：类型变异分析，2023 年和 2030 年
  • 心血管
  • 整形外科
  • 眼科

第五章 医学仿生技术市场：依应用估算与趋势分析

  • 细分仪表板
  • 医疗仿生技术市场：2023 年和 2030 年应用变化分析
  • 伤口癒合
  • 组织工程
  • 药物输送
  • 其他用途

第六章 医学仿生技术市场：区域估计与趋势分析

  • 2023 年及 2030 年医疗仿生技术市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Otsuka Medical Devices Group
    • Stryker
    • Abbott
    • AVINENT Science and Technology
    • SynTouch Inc.
    • Osteopore International Pte Ltd
    • Vandstrom, Inc.
    • Biomimetics Technologies Inc
    • Swedish Biomimetics 3000 ApS
    • Keystone Dental Group
    • LifeMatrix
    • Curasan, Inc.
    • CorNeat Vision
简介目录
Product Code: GVR-4-68039-995-0

Medical Biomimetics Market Growth & Trends:

The global medical biomimetics market size is expected to reach USD 55.36 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.

The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.

On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.

Medical Biomimetics Market Report Highlights:

  • By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
  • The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
  • The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
  • North America dominated the global medical biomimetics market in 2023 due to the high R&D investment, development of novel products, and strong funding from the government in the region
  • The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Biomimetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Biomimetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Biomimetics Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Biomimetics Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Cardiovascular
    • 4.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Orthopedic
    • 4.4.1. Orthopedic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Ophthalmology
    • 4.5.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Medical Biomimetics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Medical Biomimetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Wound Healing
    • 5.3.1. Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Tissue Engineering
    • 5.4.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Drug Delivery
    • 5.5.1. Drug Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Other Applications
    • 5.6.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Medical Biomimetics Market: Regional Estimates & Trend Analysis

  • 6.1. Medical Biomimetics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Medical Biomimetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Otsuka Medical Devices Group
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Stryker
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Abbott
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. AVINENT Science and Technology
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. SynTouch Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Osteopore International Pte Ltd
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Vandstrom, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Biomimetics Technologies Inc
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Swedish Biomimetics 3000 ApS
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Keystone Dental Group
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. LifeMatrix
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Curasan, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. CorNeat Vision
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives